ArticleJournal of diabetes science and technology2020

Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Theocharis Koufakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.